The CEO of a group of London hospitals has told the Dutch newspaper Algemeen Dagblad that he has received instructions from the British government to make concrete plans for two million Londoners to receive the new coronavirus vaccine in early December.
Dutchman Marcel Levi is the CEO of University College London Hospitals (UCLH) as well as a professor and dean at University College London. He heads seven teaching hospitals in London.
In an interview published in Algemeen Dagblad this morning (Saturday, October 31), Levi said that concrete plans are underway for the vaccination to be administered to millions of people in the United Kingdom starting in early December.
New coronavirus vaccine to roll out before Christmas
Levi said the British government has commissioned him make a plan to vaccinate some two million London residents against corona starting in early December.
“I was given a pretty difficult assignment last week,” he said. “I’ve been tasked with making a detailed plan, including locations, for the vaccination of two million people in North and Central London between the first and third weeks of December. So that’s very concrete,” he said.
“Everyone is enthusiastic. People are thinking this is the light at the end of the tunnel. Let’s go for it,” Levi added.
Several thousand staff at the University College London Hospitals, which Levi leads, are participating in the Phase 3 study of the AstraZeneca vaccine. Levi himself also got an injection. “I had pain in my arm for two days, muscle pain. Thirty percent of people get a little fever, like the flu. That is why it is also advisable to take paracetamol before vaccination. But the staff are doing well,” he said. “I don’t know anyone who has any major complaints.”
In the Western world, the pharmaceutical companies AstraZeneca and Pfizer are the furthest along in developing a COVID-19 vaccine. Levi said that “everything indicates that these two vaccines have a good immune response against the coronavirus and are safe.”
“I don’t think it’s rocket science,” Levi told the newspaper. “AstraZeneca’s Oxford vaccine is now being tested on 50,000 people, and one person has experienced a serious side effect but has also recovered. Contrast that to the many hundreds of people who die every day, to hospitals that are filling up. And the only remedy we have now is shutting down society. Shouldn’t we have the courage to say: we will release it?”
“You take a certain risk by releasing the vaccine now. But it is a limited, very small risk,” he said. “And you take that because the alternative is much worse. Let’s assume there’s a 1 in 50,000 risk of a serious side effect with the Oxford vaccine. The chance that you will have a traffic accident in the Netherlands is 1 in 1000 per year. Nobody is talking about that. You have to put things in perspective.”
In the Netherlands, Health Minster Hugo de Jonge has taken a more cautious approach. He has said that a vaccine is unlikely to become available in the Netherlands before the first months of 2021.
“If there are images from England of rows of people getting vaccinated,” Levi said, “then I think it will happen everywhere, including in the Netherlands. That’s the way politicians are.”
Social psychology in the news:
- As we age, our social skills decline – we look at people’s faces less during conversations, causing us to miss valuable social information.
- FoMO, or Fear of Missing Out, isn’t just a young person’s thing. In fact, it has a lot more to do with loneliness and social anxiety.
- A new study has found that 15 minutes of cardiovascular exercise improved performance on video games such as League of Legends.
- Toddlers who use touchscreens are faster at finding visual targets on a screen, according to a newly published study.
- New research suggests that a single episode of binge drinking in young adults may be linked to almost immediate structural brain atrophy.
Photo: ThisisEngineering RAEng via Unsplash